Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.45173 | 18 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.42714 | 18 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.42286 | 17 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.37649 | 17 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.37332 | 17 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.48099 | 17 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.45684 | 18 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.41099 | 18 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.41134 | 18 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.41627 | 18 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.41114 | 17 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.40141 | 18 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.4266 | 18 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.41931 | 18 |